Breaking News

Avid Completes Bio-Facility Upgrades

Invests in manufacturing infrastructure

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Avid Bioservices has completed upgrades to its manufacturing infrastructure and systems to meet increased demand for services and the potential commercialization of Peregrine’s bavituximab and Cotara.   Avid has enhanced its Reverse Osmosis Deionized (RODI) and Water for Injection (WFI) systems, resulting in a 450% increase in water capacity to support increased production. Other projects include a contract with Advanced BioScience Laboratories to provide development and large-scale manufa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters